Verona Pharma plc
VRNA
$105.27
$0.070.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 116.83% | 36.73% | -139.36% | -192.52% | -704.30% |
| Total Depreciation and Amortization | 8.52% | 12.17% | 24.52% | 71.61% | 71.97% |
| Total Amortization of Deferred Charges | 240.89% | 697.56% | 3,953.85% | 654.37% | -- |
| Total Other Non-Cash Items | 75.14% | 755.44% | 463.69% | -264.30% | 339.34% |
| Change in Net Operating Assets | -147.23% | -584.86% | -12,096.77% | -149.63% | 299.54% |
| Cash from Operations | 278.70% | 15.06% | -177.22% | -392.30% | 19.75% |
| Capital Expenditure | 100.00% | -3,243.75% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -3,243.75% | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 532.97% | -- | 7,541.67% | -100.00% |
| Repurchase of Common Stock | 100.00% | -3,094.63% | 9.07% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -97.04% | 530.90% | 292.12% | -14,864.58% | 134,441.94% |
| Foreign Exchange rate Adjustments | 6,756.25% | 310.64% | -234.30% | 273.46% | -96.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.55% | 109.82% | 342.29% | -413.13% | 823.69% |